Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
Montserrat García‐Closas(Institute of Cancer Research), Jenny Chang‐Claude(Universität Hamburg), Peter Schürmann(Hannover Re (Germany)), Natalia Bogdanova(Medizinische Hochschule Hannover), Thilo Dörk(Hannover Re (Germany)), Thomas Bruening(Ruhr University Bochum), Matti Eskelinen(University of Eastern Finland), Karen A. Pooley(University of Cambridge), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Gloría Ribas(Spanish National Cancer Research Centre), Anna González‐Neira(Spanish National Cancer Research Centre), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Roger L. Milne(The University of Melbourne), Christi J. van Asperen(Loyola University Medical Center), José Ignacio Arias(Spanish National Cancer Research Centre), Jonathan J. Morrison(Uniformed Services University of the Health Sciences), Peter Devilee(Leiden University), Matti Uusitupa(University of Eastern Finland), Javier Benı́tez(Spanish National Cancer Research Centre), Per Hall(Karolinska Institutet), Vesa Kataja(Kuopio University Hospital), Petra E.A. Huijts(Leiden University), Heli Nevanlinna(University of Helsinki), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Carl Blomqvist(University of Helsinki), Michael Bremer(Medizinische Hochschule Hannover), Kirsimari Aaltonen(University of Helsinki), C. K. Axelsson(University of Copenhagen), Rainer Fagerholm(358 (Finland)), Maria Tengström(Kuopio University Hospital), Karl von Smitten(Helsinki University Hospital), Stig E. Bojesen(University of Copenhagen), Børge G. Nordestgaard(Gentofte Hospital), Catharina E. Jacobi(Leiden University Medical Center), Pilar Zamora(Hospital Universitario La Paz), Ute Hamann(German Cancer Research Center), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Kristiina Aittomäki(University of Helsinki), Johann H. Karstens(Medizinische Hochschule Hannover), Yon‐Dschun Ko(Johanniter-Krankenhaus Bonn), Veli‐Matti Kosma(University of Eastern Finland), Susanne Haas, Jan G.M. Klijn(German Cancer Research Center), Douglas Richesson(National Cancer Institute), Peter Hillemanns(Medizinische Hochschule Hannover), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Hiltrud Brauch(German Cancer Research Center)
Cited by 395
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k